Metabolomic Technologies Inc. develops metabolomics-based in vitro diagnostics for cancer, including urine-based PolypDx for colorectal cancer.
Get notified the moment Metabolomycs, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.